OFFER TERMS: By using the Pfizer Factor Savings Card, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below: The Card is not valid for prescriptions that are eligible to be reimbursed, in whole or in part, by Medicaid, Medicare or any other federal or state healthcare programs (including any state prescription drug assistance programs and the Government Health Insurance Plan, available in Puerto Rico, formerly known as “La Reforma de Salud”). The Card is not valid for prescriptions that are eligible to be reimbursed by private insurance plans or other health or pharmacy benefit programs which reimburse you for the entire cost of your prescription drugs. You may receive a total benefit of $12,000 over 12 months, or the amount of your co-pay over 12 months less a patient financial responsibility of $10 per month, whichever is less. You must deduct the value of this offer from any reimbursement requests submitted to your insurance plan either by you or on your behalf. The Card is not valid where otherwise prohibited by law. The Card cannot be combined with any other rebate/coupon, free trial, or similar offer for the specified prescription. The card will be accepted only at participating factor suppliers. This coupon is not health insurance. Offer good only in the U.S. and Puerto Rico. The Card is limited to 1 per person during this offering period and is not transferable. Offer limited to one use per month up to 12 times per patient per year. Pfizer reserves the right to rescind, revoke, or amend this offer without notice. Offer expires 12/31/17. No membership fees.
Xyntha
Important Safety Information and Indication
- Do not use in patients who have manifested life-threatening immediate hypersensitivity reactions, including anaphylaxis, to the product or its components, including hamster proteins.
- Allergic-type hypersensitivity reactions, including anaphylaxis, are possible with XYNTHA®. Inform patients of the early signs or symptoms of hypersensitivity reactions (including hives, generalized urticaria, chest tightness, wheezing, and hypotension) and anaphylaxis. Discontinue XYNTHA if hypersensitivity symptoms occur and administer appropriate emergency treatment. XYNTHA contains trace amounts of hamster proteins. Patients may develop hypersensitivity to these proteins.
- Inhibitors have been reported following administration of XYNTHA. Monitor patients for the development of factor VIII inhibitors by appropriate clinical observations and laboratory tests.
- Clinical response to XYNTHA may vary. If bleeding is not controlled with the recommended dose of factor, determine the plasma level and administer a dose of XYNTHA sufficient to achieve clinical response. If the factor level does not increase or there is no response, suspect an inhibitor and perform appropriate testing.
- Across all studies, the most common adverse reactions (≥10%) with XYNTHA in previously treated adult and pediatric patients were headache (26% of subjects), arthralgia (25%), fever (21%), and cough (11%). Other adverse reactions reported in ≥5% of subjects were diarrhea, vomiting, weakness, and nausea.
- XYNTHA is an injectable medicine administered by intravenous (IV) infusion. Patients should be advised that local irritation may occur when infusing XYNTHA after reconstitution in XYNTHA® SOLOFUSE®.
Indication
Xyntha® Antihemophilic Factor (Recombinant) is indicated in adults and children with hemophilia A (congenital factor VIII deficiency or classic hemophilia) for control and prevention of bleeding episodes and for perioperative management.
XYNTHA does not contain von Willebrand factor and, therefore, is not indicated in von Willebrand’s disease.
Please see full Prescribing Information for XYNTHA and XYNTHA SOLOFUSE.
Indicated to prevent and control bleeds. XYNTHA SOLOFUSE can help prepare your patients who live actively.1
Proven Efficacy1
XYNTHA® demonstrates proven bleed control and prevention in patients with hemophilia A
Established Safety Profile1
Across clinical trials of PTPs, XYNTHA has demonstrated a low rate of inhibitor formation
All-In-One Reconstitution1
XYNTHA® SOLOFUSE® comes in a travel-ready kit and keeps your patients ready to infuse on the go
Trial Prescription Program
Help your eligible patients get started on XYNTHA with a free trial offer
Pfizer Factor Savings Card
See how your eligible patients may save money on XYNTHA each year. Terms and conditions apply.
